Early research (Phase 1)Active Not RecruitingNCT02817633What this trial is testingTSR-022 in Participants With Advanced Solid Tumors (AMBER)Who this might be right forNeoplasms Tesaro, Inc. 463
Testing effectiveness (Phase 2)Study completedNCT02240238What this trial is testingCombination Therapy With NC-6004 and Gemcitabine in Advanced Solid Tumors or Non-Small Cell Lung, Biliary and Bladder CancerWho this might be right forSolid Tumors NanoCarrier Co., Ltd. 119
Not applicableWithdrawnNCT00897143What this trial is testingIdentifying Early Lung Cancer Cells in Malignant Pleural Effusion Samples From Patients With Primary Lung CancerWho this might be right forLung CancerMetastatic Cancer Case Comprehensive Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT05176925What this trial is testingTislelizumab Combined With Sitravatinib as Consolidation Treatment Following Concurrent Chemoradiation in Patients With Locally Advanced, Unresectable NSCLCWho this might be right forNon-small Cell Lung Cancer Fudan University 5
Testing effectiveness (Phase 2)UnknownNCT05458726What this trial is testingCorrelation Between Efficacy of Osimertinib and EGFR T790M Status and Ratio Via ddPCR in NSCLCWho this might be right forEGFR T790MOsimertinibNon-small Cell Lung Cancer+1 more Peking Union Medical College 80
Not applicableStudy completedNCT00899535What this trial is testingCancer Genome Study Using Samples From Patients With Stage I or Stage II Non-Small Cell Lung Cancer Treated on Clinical Trial ACOSOG-Z0030Who this might be right forLung Cancer Alliance for Clinical Trials in Oncology 70
Post-approval studies (Phase 4)UnknownNCT01665417What this trial is testingIcotinib as First-line and Maintenance Treatment in EGFR Mutated Patients With Lung AdenocarcinomaWho this might be right forEGFR Positive Non-small Cell Lung CancerAdenocarcinoma Betta Pharmaceuticals Co., Ltd. 100
Early research (Phase 1)Ended earlyNCT04892017What this trial is testingStudy of Inlexisertib (DCC-3116) in Participants With RAS/MAPK Pathway Mutant Solid TumorsWho this might be right forNon-Small Cell Lung CancerAdvanced Solid TumorMetastatic Solid Tumor Deciphera Pharmaceuticals, LLC 91
Testing effectiveness (Phase 2)Looking for participantsNCT07276789What this trial is testingEfficacy and Safety of a Single Dose of LS301-IT for Fluorescence Intraoperative Molecular Imaging (IMI) for Patients Undergoing Lung Cancer Resection for Non Small Cell Lung CancerWho this might be right forNon Small Cell Lung Cancer (NSCLC) Integro Theranostics 35
Not applicableStudy completedNCT04187768What this trial is testingImmunological Profile Changes In Patients With Advanced Non-Small Cell Lung CancerWho this might be right forNon Small Cell Lung CancerNon Small Cell Lung Cancer MetastaticHealthy Indiana University 29
Early research (Phase 1)Study completedNCT00560573What this trial is testingStudy Of CP-751,871 In Combination With Cisplatin And Gemcitabine In Chemotherapy-Naïve Patients With Advanced Non-Small Cell Lung CancerWho this might be right forCarcinoma, Non-Small-Cell Lung Pfizer 46
Early research (Phase 1)Looking for participantsNCT07181473What this trial is testingEvaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid TumorsWho this might be right forLung Cancer (NSCLC)Prostate CancerEsophageal Cancer+1 more Phrontline Biopharma 200
Not applicableNot Yet RecruitingNCT06922266What this trial is testingPersonalizing Adoptive Cell Transfer for Solid Tumors: Towards a New Patient-tailored Treatment OptionWho this might be right forCarcinoma, Non-Small-Cell Lung Ospedale San Raffaele 20
Not applicableNot Yet RecruitingNCT07661251What this trial is testingITTACA (Immunotherapy Time Teller for Advanced Lung Cancer)Who this might be right forNon-Small Cell Lung Cancer Laura Longshaw 60
Testing effectiveness (Phase 2)Study completedNCT00118183What this trial is testingDocetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerWho this might be right forAdenocarcinoma of the LungAdenosquamous Cell Lung CancerLarge Cell Lung Cancer+5 more National Cancer Institute (NCI) 62
Testing effectiveness (Phase 2)Study completedNCT00547105What this trial is testingErlotinib and SBRT in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung CancerWho this might be right forLung Cancer University of Texas Southwestern Medical Center 24
Testing effectiveness (Phase 2)Ended earlyNCT04495894What this trial is testingPre-Incisional Ketorolac for Patients Undergoing Surgery for Non-Small Cell Lung Cancer and Renal Cell CarcinomaWho this might be right forNon-small Cell Lung CancerRenal Cell Carcinoma Emory University 68
Early research (Phase 1)Ended earlyNCT02342353What this trial is testingPacritinib in Patients With Endothelial Growth Factor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC) After EGFR Tyrosine Kinase Inhibitor (TKI)Who this might be right forNon-Small Cell Lung CancerNonsmall Cell Lung CancerCarcinoma, Non-Small-Cell Lung Washington University School of Medicine 8
Early research (Phase 1)Looking for participantsNCT04686305What this trial is testingPhase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLCWho this might be right forLocally Advanced or Metastatic Non-Small Cell Lung Cancer AstraZeneca 304
Large-scale testing (Phase 3)Ended earlyNCT04588246What this trial is testingComparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic RadiosurgeryWho this might be right forAnatomic Stage IV Breast Cancer AJCC v8Metastatic Lung Non-Small Cell CarcinomaMetastatic Lung Small Cell Carcinoma+9 more NRG Oncology 19